Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization

Insights

Human alveolar macrophages (AM) release two substances that attract polymorphonuclear granulocytes (PMN), potentially amplifying lung inflammation after encountering foreign materials. This finding offers insights into immune responses in the airways.

Area of Science:

  • Pulmonary immunology
  • Cellular biology
  • Inflammation research

Background:

  • Alveolar macrophages (AM) are crucial phagocytic cells in the lung's terminal airways.
  • These cells encounter inhaled foreign materials and particulates.
  • Understanding AM's role in modulating inflammatory responses is vital for lung health.

Purpose of the Study:

  • To investigate the mechanisms by which alveolar macrophages control or amplify lung inflammation.
  • To identify substances released by human AM that influence inflammatory cell recruitment.

Main Methods:

  • In vitro culture of normal human alveolar macrophages (AM) from eight subjects.
  • Stimulation of AM with aggregated human immunoglobulin (Ig)G or zymosan particles.
  • Characterization of released chemoattractant substances using gel filtration, electrofocusing, and enzymatic sensitivity assays.

Main Results:

  • AM produced and released two chemoattractant substances for blood polymorphonuclear granulocytes (PMN).
  • Release was stimulated by aggregated IgG, zymosan, or simple macrophage adhesion.
  • The larger substance (10,000 daltons) is distinct from C5a and interacts with a different PMN receptor.

Conclusions:

  • Human alveolar macrophages produce at least two factors that attract PMN.
  • This capability can augment local inflammatory responses in the lung parenchyma.
  • Further characterization of these factors may reveal therapeutic targets for inflammatory lung diseases.

Related Concept Videos